Business Wire

DIGITAL-VAULT-SERVICES

19.1.2021 20:44:44 CET | Business Wire | Press release

Share
Digital Vault Services GmbH launches its market solution for Digital Guarantees

Digital Vault Services GmbH (www.digitalvaultservices.com ) is pleased today to announce the launch of Guarantee Vault, its solution for digital guarantees which went live on the 18 January 2021.

Guarantee Vault is a central register for the issuance and safe keeping of digital guarantees. It gives banks & sureties the possibility to centrally issue and store instruments such as Bank Guarantees, Surety Bonds and Standby Letters of Credit in an electronic form.

Sven Matzelsberger, Head of Treasury at Lindner Group KG stated “Guarantee Vault has been a true market collaboration between corporates, sureties and banks. Our shared experiences, collaborative spirit and common vision are at the heart and soul of what Guarantee Vault is.

We proudly see this as a true market initiative, one that solves a wide spread common problem and brings efficiencies to all involved.“

Guarantee Vault is the result of a 2 year collaboration with 16 working group partners made up of major corporates, banks and sureties including Bayerische Landesbank , BNP Paribas, HSBC, Atradius Kreditversicherung, Coface, Euler Hermes, GlobalTrade Corporation, Nokia, PORR AG, Lindner Group KG, Eurovia, Strabag and Siemens AG.

Guarantee Vault offers the unique combination of central issuance with digital guarantees, an innovation that delivers significant value to all market participants. Through the transparency it brings, Guarantee Vault adds an additional layer of efficiency right throughout the guarantee life-cycle .

Brigitte Schmidt, Head of Guarantees at Bayerische Landesbank explained “It has been a great experience working with both corporate and financial stakeholders on the digitization of guarantees.

Through Guarantee Vault we now have the possibility to offer all our customers the issuance, safe keeping and administration of digital guarantees in a secure and central place.

For the first time, the complete end-to-end digitization of the entire guarantee transaction is possible, from applicant and issuer right through to beneficiary.”

Guarantee Vault offers long-term, secure and cost-effective services to applicants, guarantors, beneficiaries and intermediaries right across the life of a guarantee including application, issuance and post-issuance (amendment, release, claim).

Delivering its service via its suite of REST APIs , Guarantee Vault allows market participants the possibility to seamlessly connect and benefit via their existing platforms, portals or other “in-house” systems.

Nicole Kerndler, Deputy Head of Bank Guarantee Management at PORR AG, added “For many years the lack of transparency in the Guarantee process has been an on-going problem for us. Because of this, managing our portfolio of outstanding guarantees across all our banking and surety partners has been a significant challenge. Through the added transparency it brings, Guarantee Vault gives us today oversight at source which solves the problem”.

Oliver Jacobs, Head of Bond Production at Euler Hermes said “Running a paper based manual guarantee process has always been a challenge, even more so in this Covid-19 environment. We believe that digital guarantees are the solution, they increase transparency, create efficiencies and minimize risk. The innovation that Guarantee Vault brings will benefit all parties including applicants, guarantors and beneficiaries”.

In the end Guarantee Vault is an open solution that allows market participants to save costs, improve efficiency, reduce operational risks and more.

“This is a first universal digital network that connects corporates with all types of guarantee issuers: banks, insurance companies, agents as well as export development and other government agencies. It also directly links corporates with each other, as applicants and beneficiaries. The Guarantee Vault offering is based on open collaboration and transparent pricing. This approach facilitates acceptance by providers of trade finance IT solutions – one of the key elements for the wider market adoption.” noted Nick Pachnev, CEO of GlobalTrade Corporation.

“We are extremely excited and proud about the launch of Guarantee Vault, the achievements made to date have been great and would not have been possible without the help and support of our working group members.

Guarantee Vault is an idea born from the market for the market, it is fully geared to fundamentally resolve long standing market pain points. A testament to this is the market interest we have had to date, in addition to our working group members, we already have a number of other corporates, sureties and banks expressing strong interest.

We are excited about our plans for 2021 and are well positioned for our initial roll-out into Europe starting with Germany and Austria followed by France and Switzerland in Q4.” stated Ludger Janßen, Managing Director Digital Vault Services GmbH.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release

If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids

Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release

Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use

DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release

-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye